All In MedTech

Device Trial Radar · NCT01656174

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

Last checked: Nov 19, 2026Latest source record: Mar 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

35,035

Actual

Start

Aug 2012

Primary completion

Dec 2014

Study completion Jan 2015

Sponsor

Lead sponsor
Gen-Probe, IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Aug 2, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.

Conditions

  • Dengue

Interventions

  • Procleix Dengue Virus AssayDevice

    in vitro diagnostic assay

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Qualitative detection of ribosomal RNA from Dengue Virus in plasma specimens from individual human donors, including volunteer donors of whole blood and blood components, and other living donors.Time frame: Approximately three years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Creative Testing Solutions

    Tempe, Arizona

  • American Red Cross National Testing Laboratory

    Charlotte, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.